BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-2.44 Cr | ₹2.71 Cr | ₹0.37 Cr | ₹0.09 Cr | ₹0.17 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAL PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-2.44 Cr |
| Mar2024 | ₹2.71 Cr |
| Mar2023 | ₹0.37 Cr |
| Mar2022 | ₹0.09 Cr |
| Mar2021 | ₹0.17 Cr |
How is Net Cash Inflow / Outflow of BAL PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.44 Cr | Negative | |
| Mar2024 | ₹2.71 Cr | 624.33 | |
| Mar2023 | ₹0.37 Cr | 320.22 | |
| Mar2022 | ₹0.09 Cr | -47.02 | |
| Mar2021 | ₹0.17 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹132.9 Cr | -5.2% | -4.9% | -18.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -5.2% |
-4.9% |
-18.9% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses